GH Research PLC (GHRS) stock
GHRSNasdaqPharmaceutical PreparationsFiscal year ends December 31
$17.53−1.03 (-5.55%)
Close on Nov 20, 2026Market cap $1.09BP/E –Yield –
GH Research net income
Net income is the profit left for shareholders after every expense, interest and tax.
GH Research's net income for the twelve months ending Jun 30, 2026 was -$62.27M. For fiscal 2025 it was -$48.26M. The highest annual figure on record is -$310.00K in fiscal 2019.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$48.26M | – |
| FY2024 | Dec 31, 2024 | -$38.96M | – |
| FY2023 | Dec 31, 2023 | -$35.59M | – |
| FY2022 | Dec 31, 2022 | -$22.46M | – |
| FY2021 | Dec 31, 2021 | -$9.20M | – |
| FY2020 | Dec 31, 2020 | -$446.00K | – |
| FY2019 | Dec 31, 2019 | -$310.00K | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$15.15M | – |
| Q1 FY2026 | Mar 31, 2026 | -$18.97M | – |
| Q4 FY2025 | Dec 31, 2025 | -$14.14M | – |
| Q3 FY2025 | Sep 30, 2025 | -$14.02M | – |
| Q2 FY2025 | Jun 30, 2025 | -$9.29M | – |
| Q1 FY2025 | Mar 31, 2025 | -$10.81M | – |
| Q4 FY2024 | Dec 31, 2024 | -$8.80M | – |
| Q3 FY2024 | Sep 30, 2024 | -$12.11M | – |
| Q2 FY2024 | Jun 30, 2024 | -$10.38M | – |
| Q1 FY2024 | Mar 31, 2024 | -$7.67M | – |
| Q4 FY2023 | Dec 31, 2023 | -$11.27M | – |
| Q3 FY2023 | Sep 30, 2023 | -$5.65M | – |
| Q2 FY2023 | Jun 30, 2023 | -$7.73M | -2414.1% |
| Q1 FY2023 | Mar 31, 2023 | -$10.94M | – |
| Q4 FY2022 | Dec 31, 2022 | -$16.59M | – |
| Q3 FY2022 | Sep 30, 2022 | -$441.00K | – |
| Q2 FY2022 | Jun 30, 2022 | $334.00K | – |
See a number that looks wrong?